Association of variants in the carnosine peptidase 1 gene (CNDP1) with diabetic nephropathy in American Indians

Molecular Genetics and Metabolism

Volumn 103, Issue 2, 2011, Pages 185-190

  Chakkera, Harini A ^a,b   Hanson, Robert L ^b   Kobes, Sayuko ^b   Millis, Meredith P ^c   Nelson, Robert G ^b   Knowler, William C ^b   Distefano, Johanna K ^c  

^a MAYO CLINIC   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

Kidney disease; Proteinuria; Single nucleotide polymorphism

Indexed keywords

CARNOSINE; CARNOSINE DIPEPTIDASE 1; DIPEPTIDASE; UNCLASSIFIED DRUG;

ADULT; ALLELE; AMERICAN INDIAN; ARTICLE; CNDP 1 GENE; DIABETIC NEPHROPATHY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIPEPTIDASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIANS, NORTH AMERICAN; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

PIMA;

EID: 79956280805     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.02.010     Document Type: Article

References (40)

1. United States Renal Data System, United States Renal Data System 2009 Annual Report. 2, 231-240.
2. Lemley K.V. A basis for accelerated progression of diabetic nephropathy in Pima Indians Kidney international 2003, S38-S42.
3. Pugh J.A., Medina R., Ramirez M. Comparison of the course to end-stage renal disease of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic nephropathy. Diabetologia 1993, 36:1094-1098.
4. Borch-Johnsen K., Norgaard K., Hommel E., Mathiesen E.R., Jensen J.S., Deckert T., Parving H.H. Is diabetic nephropathy an inherited complication?. Kidney International 1992, 41:719-722.
5. Pettitt D.J., Saad M.F., Bennett P.H., Nelson R.G., Knowler W.C. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1990, 33:438-443.
6. Quinn M., Angelico M.C., Warram J.H., Krolewski A.S. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996, 39:940-945.
7. Seaquist E.R., Goetz F.C., Rich S., Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. The New England Journal of Medicine 1989, 320:1161-1165.
8. Bowden D.W., Colicigno C.J., Langefeld C.D., Sale M.M., Williams A., Anderson P.J., Rich S.S., Freedman B.I. A genome scan for diabetic nephropathy in African Americans. Kidney International 2004, 66:1517-1526.
9. Iyengar S.K., Abboud H.E., Goddard K.A., Saad M.F., Adler S.G., Arar N.H., Bowden D.W., Duggirala R., Elston R.C., Hanson R.L., Ipp E., Kao W.H., Kimmel P.L., Klag M.J., Knowler W.C., Meoni L.A., Nelson R.G., Nicholas S.B., Pahl M.V., Parekh R.S., Quade S.R., Rich S.S., Rotter J.I., Scavini M., Schelling J.R., Sedor J.R., Sehgal A.R., Shah V.O., Smith M.W., Taylor K.D., Winkler C.A., Zager P.G., Freedman B.I. Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes 2007, 56:1577-1585.
10. Vardarli I., Baier L.J., Hanson R.L., Akkoyun I., Fischer C., Rohmeiss P., Basci A., Bartram C.R., Van Der Woude F.J., Janssen B. Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney International 2002, 62:2176-2183.
11. Freedman B.I., Hicks P.J., Sale M.M., Pierson E.D., Langefeld C.D., Rich S.S., Xu J., McDonough C., Janssen B., Yard B.A., van der Woude F.J., Bowden D.W. A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans. Nephrology Dialysis and Transplantation 2007, 22:1131-1135.
12. Janssen B., Hohenadel D., Brinkkoetter P., Peters V., Rind N., Fischer C., Rychlik I., Cerna M., Romzova M., de Heer E., Baelde H., Bakker S.J., Zirie M., Rondeau E., Mathieson P., Saleem M.A., Meyer J., Koppel H., Sauerhoefer S., Bartram C.R., Nawroth P., Hammes H.P., Yard B.A., Zschocke J., van der Woude F.J. Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes 2005, 54:2320-2327.
13. Mooyaart A.L., van Valkengoed I.G., Shaw P.K., Peters V., Baelde H.J., Rabelink T.J., Bruijn J.A., Stronks K., de Heer E. Lower frequency of the 5/5 homozygous CNDP1 genotype in South Asian Surinamese. Diabetes Research and Clinical Practice 2009, 85:272-278.
14. C.W. Mcdonough, M.A. Bostrom, L. Lu, P.J. Hicks, C.D. Langefeld, J. Divers, J.C. Mychaleckyj, B.I. Freedman, D.W. Bowden, Genetic analysis of diabetic nephropathy on chromosome 18 in African Americans: linkage analysis and dense SNP mapping, Human Genetics 126 (6), 805-817, doi:10.1007/s00439-009-0732-8.
15. McDonough C.W., Hicks P.J., Lu L., Langefeld C.D., Freedman B.I., Bowden D.W. The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African-Americans. Human Genetics 2009, 126:265-275.
16. Guiotto A., Calderan A., Ruzza P., Borin G. Carnosine and carnosine-related antioxidants: a review. Current Medicinal Chemistry 2005, 12:2293-2315.
17. Knowler W.C., Bennett P.H., Hamman R.F., Miller M. Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. American Journal of Epidemiology 1978, 108:497-505.
18. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997, 20:1183-1197.
19. Vasquez B., Flock E.V., Savage P.J., Nagulesparan M., Bennion L.J., Baird H.R., Bennett P.H. Sustained reduction of proteinuria in type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycaemia. Diabetologia 1984, 26:127-133.
20. Wolford J.K., Yeatts K.A., Red Eagle A.R., Nelson R.G., Knowler W.C., Hanson R.L. Variants in the gene encoding aldose reductase (AKR1B1) and diabetic nephropathy in American Indians. Diabetic Medicine 2006, 23:367-376.
21. Imperatore G., Hanson R.L., Pettitt D.J., Kobes S., Bennett P.H., Knowler W.C. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes 1998, 47:821-830.
22. Nelson R.G., Bennett P.H., Beck G.J., Tan M., Knowler W.C., Mitch W.E., Hirschman G.H., Myers B.D. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. The New England Journal of Medicine 1996, 335:1636-1642.
23. Nelson R.G., Knowler W.C., McCance D.R., Sievers M.L., Pettitt D.J., Charles M.A., Hanson R.L., Liu Q.Z., Bennett P.H. Determinants of end-stage renal disease in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus and proteinuria. Diabetologia 1993, 36:1087-1093.
24. Kamenetzky S.A., Bennett P.H., Dippe S.E., Miller M., LeCompte P.M. A clinical and histologic study of diabetic nephropathy in the Pima Indians. Diabetes 1974, 23:61-68.
25. Lemley K.V., Abdullah I., Myers B.D., Meyer T.W., Blouch K., Smith W.E., Bennett P.H., Nelson R.G. Evolution of incipient nephropathy in type 2 diabetes mellitus. Kidney International 2000, 58:1228-1237.
26. Pagtalunan M.E., Miller P.L., Jumping-Eagle S., Nelson R.G., Myers B.D., Rennke H.G., Coplon N.S., Sun L., Meyer T.W. Podocyte loss and progressive glomerular injury in type II diabetes. The Journal of Clinical Investigation 1997, 99:342-348.
27. National Center for Biotechnology Information/National Library of Medicine/National Institutes of Health International HapMap Project Available at:, Accessed 07/02/2007. http://hapmap.ncbi.nlm.nih.gov.
28. Conrad D.F., Jakobsson M., Coop G., Wen X., Wall J.D., Rosenberg N.A., Pritchard J.K. A worldwide survey of haplotype variation and linkage disequilibrium in the human genome. Nature Genetics 2006, 38:1251-1260.
29. de Bakker P.I., Yelensky R., Pe'er I., Gabriel S.B., Daly M.J., Altshuler D. Efficiency and power in genetic association studies. Nature Genetics 2005, 37:1217-1223.
30. Craig D.W., Millis M.P., Distefano J.K. Genome-wide SNP genotyping study using pooled DNA to identify candidate markers mediating susceptibility to end-stage renal disease attributed to Type 1 diabetes. Diabetic Medicine 2009, 26:1090-1098.
31. Wanic K., Placha G., Dunn J., Smiles A., Warram J.H., Krolewski A.S. Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies. Diabetes 2008, 57:2547-2551.
32. Duggal P., Gillanders E.M., Holmes T.N., Bailey-Wilson J.E. Establishing an adjusted p-value threshold to control the family-wide type 1 error in genome wide association studies. BioMed Central Genomics 2008, 9:516.
33. Imperatore G., Knowler W.C., Pettitt D.J., Kobes S., Bennett P.H., Hanson R.L. Segregation analysis of diabetic nephropathy in Pima Indians. Diabetes 2000, 49:1049-1056.
34. Nelson R.G., Newman J.M., Knowler W.C., Sievers M.L., Kunzelman C.L., Pettitt D.J., Moffett C.D., Teutsch S.M., Bennett P.H. Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 1988, 31:730-736.
35. Hanson R.L., Looker H.C., Ma L., Muller Y.L., Baier L.J., Knowler W.C. Design and analysis of genetic association studies to finely map a locus identified by linkage analysis: sample size and power calculations. Annals of Human Genetics 2006, 70:332-349.
36. Tregouet D.A., Groop P.H., McGinn S., Forsblom C., Hadjadj S., Marre M., Parving H.H., Tarnow L., Telgmann R., Godefroy T., Nicaud V., Rousseau R., Parkkonen M., Hoverfalt A., Gut I., Heath S., Matsuda F., Cox R., Kazeem G., Farrall M., Gauguier D., Brand-Herrmann S.M., Cambien F., Lathrop M., Vionnet N. G/T substitution in intron 1 of the UNC13B gene is associated with increased risk of nephropathy in patients with type 1 diabetes. Diabetes 2008, 57:2843-2850.
37. Poon P.Y., Szeto C.C., Kwan B.C., Chow K.M., Li P.K. Relationship between carnosinase gene CNDP1 leucine repeat polymorphism and the clinical outcome of Chinese PD patients. Clinical Nephrology 2010, 74:343-345.
38. Lin P.I., Vance J.M., Pericak-Vance M.A., Martin E.R. No gene is an island: the flip-flop phenomenon. American Journal of Human Genetics 2007, 80:531-538.
39. Hanson R.L., Knowler W.C. Design and analysis of genetic association studies to finely map a locus identified by linkage analysis: assessment of the extent to which an association can account for the linkage. Annals of Human Genetics 2008, 72:126-139.
40. Sauerhofer S., Yuan G., Braun G.S., Deinzer M., Neumaier M., Gretz N., Floege J., Kriz W., van der Woude F., Moeller M.J. L-carnosine, a substrate of carnosinase-1, influences glucose metabolism. Diabetes 2007, 56:2425-2432.